Key result
Amitriptyline and doxepin reduce HRV, whereas fluvoxamine and paroxetine show no effect.
Why the study?
The effect of different antidepressant treatments on heart rate variability in patients with major depression was unclear.
Do different antidepressants (amitriptyline, doxepin, fluvoxamine, paroxetine) alter heart rate variability in patients with major depression?
RCT (n=64)
Randomly allocated
Do different antidepressants (amitriptyline, doxepin, fluvoxamine, paroxetine) alter heart rate variability in patients with major depression?
Tricyclic antidepressants, but not SSRIs, significantly reduce heart rate variability in patients with major depression after 14 days of treatment.
Answers are grounded in this paper and cite their sources.
TCAs warrant caution in cardiac-risk patients due to HRV reduction; RCT confirms no such effect with SSRIs.
A total of 32 unmedicated patients with episodes of major depression (DSM-III-R) and 32 normal control subjects matched for age and sex were tested for heart rate variability (R-R variation) while resting and during deep breathing. Compared with the group of healthy subjects, the depressed patients showed no abnormalities before therapy. The patients were randomly allocated for treatment with 150 mg of amitriptyline per day (N = 8), 150 mg of doxepin per day (N = 8), 150 mg of fluvoxamine per day (N = 8), and 20 mg of paroxetine per day (N = 8). During treatment with either amitriptyline or doxepin, the coefficients of variation at rest and during deep breathing, which are largely independent of heart rate, had significantly decreased after 14 days (p = 0.012), whereas patients treated with fluvoxamine or paroxetine showed no significant changes of heart rate variability parameters after 14 days. The implications of these findings are discussed.
No takes yet. Share an insight, caveat, or question.
T. Rechlin (1994) conducted an RCT in Major depression (n=64). Amitriptyline, doxepin, fluvoxamine, or paroxetine vs. Active comparators and healthy controls was evaluated on Heart rate variability (coefficients of variation at rest and during deep breathing) (p=0.012). Treatment with amitriptyline or doxepin decreased heart rate variability after 14 days, whereas fluvoxamine and paroxetine produced no significant changes.
Synapse has enriched 10 related papers. Consider them for comparative context: